Sign in to view content

Intended vs Actual Intervals Between Intravitreal Anti-VEGF Injections and Assessment of Treatment Delays

Christina Y Weng, MD, MBA, FASRS

Video
Published 2023

Related

Outcomes of Intravitreal Antivascular Endothelial Growth Factor (VEGF) Therapy for Diabetic Macular Edema in Routine Clinical Practice
John D Pitcher, MD
Annual Meeting Talks
2018
Suprachoroidal CLS-TA Plus Aflibercept Compared With Aflibercept Monotherapy for DME: Results of a Phase 2 Trial
Michael S. Ip, MD
Annual Meeting Talks
2019
Episode 143: Journal Club, Pediatric Retinal Detachment Surgery, Open Label Extension RISE and RIDE, BP Changes during Injections
Jayanth Sridhar, MD
Member Podcasts
2018

Category: Pharmacology

See more